0

Validation of a Fast Liquid chromatography-UV Method for the Analysis of Drugs Used in Combined Cardiovascular Therapy in Human Plasma

Gorka Iriarte, Oskar Gonzalez, Nerea Ferreirós, Miren Itxaso Maguregui, Rosa Maria Alonso, Rosa Maria Jiménez

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Oct 1;877(27):3045-53.

PMID: 19660995

Abstract:

Ultra-performance liquid chromatography (UPLC) was investigated as a faster alternative to high-performance liquid chromatography (HPLC) for the simultaneous analysis of drugs usually prescribed in cardiovascular therapy. Upon a previously developed and validated solid phase extraction (SPE)-HPLC-photodiode array (PDA)-fluorescence (FLR) method, separation of chlorthalidone (CLTD; diuretic), valsartan and its metabolite (VAL and VAL-M1 respectively; angiotensin II receptor antagonist drugs) and fluvastatin (FLUV; statin) was performed in human plasma using an RP C18 column (50mmx2.1mm, 1.7microm, Waters Acquity UPLC (BEH)) and a tunable UV-vis (TUV) detector. After method transfer, different system variables were modulated to study the evolution of responses of the analytes and the endogenous interferences. The improved method was fully validated and the results were compared with its precursor HPLC method relating to analysis time, efficiency and sensitivity. The studied compounds were separated in less than 8min and the method showed good linearity (20-3000microg/L for chlorthalidone, 110-1100microg/L for valsartan-M1, 67-1900microg/L for valsartan and 48-1100microg/L for fluvastatin), precision and accuracy. The proposed method was found to be reproducible (RSD<10%), accurate (RE<15%), robust and suitable for quantitative analysis of the studied drugs in plasma obtained from patients under combined cardiovascular treatment.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
CS31041673 Fluvastatin for System Suitability Fluvastatin for System Suitability Price
qrcode